TBC1D1 and fatty liver disease: Here, to further explore the underlying role of AMPK-TBC1D1 signaling in hepatic steatosis, we detected NAFLD-related phenotypes in TBC1D1-KI mice at 4 to 6 months, 12 months, and 18 months of age.